Prevalence of female pattern hair loss in postmenopausal women in Saudi Arabia
Majmaah Journal of Health Sciences · 2025 · 13 (4) · 98
DOI: 10.5455/mjhs.2025.04.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Majmaah Journal of Health Sciences, 2025. Verfasst von Ghadeer Almasabi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background and Aims: Female pattern hair loss (FPHL) is a common but frequently overlooked condition that affects postmenopausal women worldwide. It impacts both physical appearance and psychosocial well-being. This study examined the prevalence, risk factors, and psychosocial consequences of FPHL among postmenopausal women in Saudi Arabia. Methods: A cross-sectional study was conducted from January to December 2025 using a self-administered online questionnaire to assess the prevalence of FPHL and associated factors among postmenopausal women from various regions of Saudi Arabia. Convenience sampling was used. Chi-square tests were used to examine the associations between categorical variables and the prevalence of hair loss among menopausal women. A p-value of
Zitieren
APA
Almasabi, G., Alhumaidi, R., Alqurqush, N., Alshehri, R., Almansour, T., Aseeri, A., & Algarni, A. (2025). Prevalence of female pattern hair loss in postmenopausal women in Saudi Arabia. Majmaah Journal of Health Sciences, 13(4), 98. https://doi.org/10.5455/mjhs.2025.04.009
Vancouver
Almasabi G, Alhumaidi R, Alqurqush N, Alshehri R, Almansour T, Aseeri A, et al. Prevalence of female pattern hair loss in postmenopausal women in Saudi Arabia. Majmaah Journal of Health Sciences. 2025;13(4):98. doi:10.5455/mjhs.2025.04.009
BibTeX
@article{Almasabi2025,
author = {Almasabi, Ghadeer and Alhumaidi, Razan and Alqurqush, Noor and Alshehri, Rizan and Almansour, Turki and Aseeri, Ahmed and Algarni, Abdullah},
title = {Prevalence of female pattern hair loss in postmenopausal women in Saudi Arabia},
journal = {Majmaah Journal of Health Sciences},
year = {2025},
volume = {13},
number = {4},
pages = {98},
doi = {10.5455/mjhs.2025.04.009}
}
EUVIMED